Bristol-Myers Squibb Company;Université de Montréal
发明人:
Banville, Jacques,Rémillard, Roger,Ruediger, Edward H.,Deon, Daniel H.,Gagnon, Marc,Dubé, Laurence,Guy, Julia,Priestley, Eldon Scott,Posy, Shoshana L.,Maxwell, Brad D.,Wong, Pancras C.,Lawrence, Micha
申请号：
HRP20171453
公开号：
HRP20171453T1
申请日:
2017.09.28
申请国别(地区):
HR
年份:
2017
代理人:
摘要：
The present invention provides thiazole compounds of Formula I wherein W, Y, R 0 , R 2 , R 4 , R 5 , R 6 , R 7 , X 1 , X 2 , X 3 and X 4 are as defined herein, or a stereoisomer, tautomer, pharmaceutically acceptable salt or solvate form thereof, wherein all of the variables are as defined herein. These compounds are inhibitors of platelet aggregation and thus can be used as medicaments for treating or preventing thromboembolic disorders.
